GSK Gets Patent Cut From Wellbutrin Antitrust Action
GlaxoSmithKline PLC has won a bid to purge all claims related to one patent in a putative class action brought by employee benefit plans that accuses the drugmaker of filing baseless...To view the full article, register now.
Already a subscriber? Click here to view full article